Quick Answer
Renalytix plc reported Earnings Per Share Diluted of $0.31 (loss) per share for the year ending 2024.
- Renalytix plc showed an increase of +43.6% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Renalytix plc's annual report (Form 10-K), filed with the SEC on September 30, 2024.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $0.16 (loss) per share | Q4 2022: $0.14 (loss) per share | Q1 2023: $0.14 (loss) per share | Q3 2023: $0.11 (loss) per share | Q4 2023: $0.09 (loss) per share | Q1 2024: $0.08 (loss) per share | Q3 2024: $0.04 (loss) per share.
- Over the full 5 years of available data (2020 to 2024), Renalytix plc's Earnings Per Share Diluted has declined by 82.4%.
- Historical annual values: Fiscal year 2024: $0.31 (loss) per share | Fiscal year 2023: $0.55 (loss) per share | Fiscal year 2022: $0.67 (loss) per share | Fiscal year 2021: $0.49 (loss) per share | Fiscal year 2020: $0.17 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: